66142-81-2COc1cc(CCN)c(OC)cc1BrYMHOBZXQZVXHBM-UHFFFAOYSA-N2,5-dimethoxy-4-bromophenethylamine is a 2-arylethylamine compound where the aryl moiety is 4-bromo-2,5-dimethoxyphenyl.
66142-81-2DEA NFLIS-Drug Category -> Phenethylamines (2C Series) (H)
DEA Schedule I Controlled Substance -> Hallucinogenic substances
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Pharmaceuticals -> Listed in ZINC15
155.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]
157.6 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated]
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]
P260, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P316, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS.
DefinitionChEBI: A 2-arylethylamine compound where the aryl moiety is 4-bromo-2,5-dimethoxyphenyl.
No reaction records under the current filter.
Loading…
DTXSID10216332CHEMBL292821CHEBI:189669